Shares of Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the seven brokerages that are currently covering the firm, ...
BMO Capital Markets said it views BioMarin Pharmaceutical (NASDAQ:BMRN), Legend Biotech (NASDAQ:LEGN) and Silence Therapeutics (NASDAQ:SLN) as attractive takeover targets following Eli Lilly’s (LLY) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback